Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
05/2003
05/08/2003US20030087936 Treating enterovirus infection
05/08/2003US20030087935 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
05/08/2003US20030087924 Diacid-substituted heteroaryl derivatives as matrix metalloproteinase inhibitors
05/08/2003US20030087922 Aryl substituted 2-aminopyrimidines and 2-aminopyridines
05/08/2003US20030087908 Substituted triazinyl amide derivatives and methods of use
05/08/2003US20030087907 Quinoline derivatives and quinazoline derivatives having azolyl group
05/08/2003US20030087902 Substituted indoles, pharmaceutical compounds containing such indoles and their use as PPAR-gamma binding agents
05/08/2003US20030087901 Compounds and methods for modulation of estrogen receptors
05/08/2003US20030087888 Anticancer agents
05/08/2003US20030087882 Antiinflammatory agents
05/08/2003US20030087306 Methods for identifying novel multimeric agents that modulate receptors
05/08/2003CA2468761A1 Novel anticancer compounds
05/08/2003CA2465350A1 Therapeutic quinoline compounds with 5-ht-antagonistic properties
05/08/2003CA2465344A1 Therapeutic quinolone compounds with 5-ht-antagonistic properties
05/08/2003CA2464353A1 Linear basic compounds having nk-2 antagonist activity and formulations thereof
05/08/2003CA2464342A1 Therapeutic isoquinoline compounds
05/08/2003CA2463822A1 Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (gsk3 inhibitors)
05/08/2003CA2463821A1 Amide derivatives as glycogen synthase kinase 3-beta inhibitors
05/08/2003CA2463441A1 Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity
05/08/2003CA2462525A1 Type 4 phosphodiesterase inhibitors and uses thereof
05/08/2003CA2462206A1 Substituted thioacetamides
05/07/2003EP1308439A1 Proline derivatives and use thereof as drugs
05/07/2003EP1307579A2 Bio-intermediates for use in the chemical synthesis of polyketides
05/07/2003EP1307460A1 Method for the production of imidazo-(1,2-c)(2,3)-benzodiazepines and intermediates in the production thereof
05/07/2003EP1307448A1 Tartrate salts of thiazolidinedione derivative
05/07/2003EP1307243A2 A medicinal aerosol formulation
05/07/2003EP1307204A1 Protease inhibitors
05/07/2003EP1307193A1 Agonists of follicle stimulating hormone activity
05/07/2003EP1214316B1 Five membered-ring compounds and utilization thereof in liquid crystal mixtures
05/07/2003EP1112251B1 Azetidine derivatives, preparation and medicines containing them
05/07/2003EP0966454B1 Disubstituted bicyclic heterocycles, their production and use as medicaments
05/07/2003EP0889863B1 Surface modified carbonate materials
05/07/2003EP0885190B1 N-substituted 4-((4'-aminobenzoyl)-oxymethyl)-piperidines having gastric prokinetic properties
05/07/2003EP0869791B1 4-substituted piperidine analogs and their use as subtype selective nmda receptor antagonists
05/07/2003EP0858464B1 Thrombin inhibitors
05/07/2003EP0765314B1 Benzoheterocyclic derivatives useful as vasopressin or oxytocin modulators
05/07/2003EP0751765B1 Sulfonamide derivatives and their use
05/07/2003EP0749433B1 (4,4-difluorobut-3-enylthio)-substituted heterocyclic or carbocyclic ring compounds having pesticidal activity
05/07/2003CN1416425A 1,5-bemzothiazepines and their use as hypolipidaemics
05/07/2003CN1107673C Pesticidal 1-aryl-3-iminopyrazoles
05/07/2003CN1107671C Imide derivatives
05/07/2003CN1107505C Synergistic combination of AIDS antiviral compounds and HIV inhibitor
05/06/2003US6559171 Muscarinic receptor modulators 7-oxo-2-azabicyclo(2.2.1)heptanes of formula (I) which are useful for the treatment of various diseases and conditions, for example, Alzheimer's disease, glaucoma, psychosis,
05/06/2003US6559168 Thiazolyl-acid amide derivatives useful as inhibitors of PDE4 isozymes
05/06/2003US6559167 Prodrugs of the pyridyl methyl sulfinyl benzimidazole type proton pump inhibitor drugs have a hydrolyzable arylsulfonyl or heteroarylsulfonyl group attached to the benzimidazole nitrogen. The prodrugs of the invention hydrolyze under
05/06/2003US6559162 Azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias
05/06/2003US6559142 Tricyclic substituted cyclic sulfonamides compound is useful for treating heart disease, multiple sclerosis, arthritis, atherosclerosis, and osteoporosis
05/06/2003US6559140 Cyclic and bicyclic diamino histamine-3 receptor antagonists
05/06/2003US6559137 Characterized by favorable aqueous solubility, high oral bioavailability and facile in vivo generation of the active ingredient
05/06/2003US6558435 Reactive crystallization method to improve particle size
05/06/2003CA2189698C Substituted 1,2,3-triazol-3-ones
05/02/2003EP1306373A1 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient
05/02/2003EP1306086A2 Use of thiazolidinediones for the treatment of atherosclerosis and eating disorders
05/02/2003EP1305312A1 Tartrate salts of thiazolidinedione derivative
05/02/2003EP1305311A1 Tartrate salt of thiazolidinedione derivative
05/02/2003EP1305310A1 Tartrate salts of thiazolidinedione derivative
05/02/2003EP1305308A1 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
05/02/2003EP1305307A1 Indole derivatives useful for the treatment of cns disorders
05/02/2003EP1305301A1 Alpha-acyl and alpha-heteroatom-substituted benzene acetamide glucokinase activators
05/02/2003EP1305295A1 Imidazole derivatives
05/02/2003EP1305294A2 Imidazolyl derivatives
05/02/2003EP1305291A1 3-substituted isoquinolin-1-yl derivatives
05/02/2003EP1305288A1 Potassium channel inhibitors
05/02/2003EP1305028A2 Antimicrobial biaryl compounds
05/02/2003EP1045846B1 Imidazole derivatives having an inhibitory activity for farnesyl transferase and process for preparation thereof
05/02/2003EP1037886B1 Triazine angiogenesis inhibitors
05/02/2003EP0967980B1 Use of aminothiazoles for treating wounds and skin
05/02/2003EP0966452B1 Process for preparing sulphurous 2-chloro-3-(4,5-dihydroisoxazol-3-yl)-benzoic acids
05/02/2003EP0901482B1 Benzofuran carboxamides and their therapeutic use
05/02/2003EP0772593B1 Thiopyridyl compounds for controlling helicobacter bacteria
05/01/2003WO2003035648A1 Aryl substituted oxazolidinones with antibacterial activity
05/01/2003WO2003035643A1 Pyrazolyl-substituted heterocycles and their use as phytosanitary products
05/01/2003WO2003035627A1 Piperazine derivatives with ccr1 receptor antagonist activity
05/01/2003WO2003035621A1 Protein kinase and phosphatase inhibitors, methods for designing them, and methods of using them
05/01/2003WO2003035615A2 Tyrosine kinase inhibitors
05/01/2003WO2003035613A2 Nitrogen heterocycle inhibitors of aspartyl protease
05/01/2003WO2003035602A1 Lipid modulators
05/01/2003WO2003035077A1 N-substituted hydroxypyrimidinone carboxamide inhibitors of hiv integrase
05/01/2003WO2003035076A1 Dihydroxypyrimidine carboxamide inhibitors of hiv integrase
05/01/2003WO2003035073A1 Isoxazoline derivatives useful as antimicrobials
05/01/2003WO2003035067A1 Novel dipeptidyl peptidase iv (dp-iv) inhibitors as anti-diabetic agents
05/01/2003WO2003035057A1 Inhibitors of dipeptidyl peptidase iv
05/01/2003WO2003006443A3 2- 4-(naphtalin-2-yl)-thiazol-2-ylaminocarbonyl benzoic acid and 2- 4-(naphtalin-2-yl)-pyrimidin-2-ylaminocarbonyl benzoic acid and additional compounds serving as telomerase inhibitors for use in tumor therapy
05/01/2003WO2003005824A3 Substituted 3-heteroaryl (amino-or-oxy)-pyrrolidin-2-ones, method for the production thereof and use thereof as herbicides or as plant growth regulators
05/01/2003WO2002102782A3 QUINAZOLINE DERIVATIVES which PROMOTE THE RELEASE OF PARATHYROID_HORMONE
05/01/2003WO2002099388A3 Benzodiazepine bradykinin antagonists
05/01/2003WO2002081478A3 Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide hiv protease inhibitors
05/01/2003WO2002079186A3 Aminopiperidine derivatives as modulators of chemokine receptor activity
05/01/2003WO2002038553A3 Triazole derivatives and their use as peroxisome proliferator activated receptor alpha agonists
05/01/2003US20030083365 Such as 1-(3-(((3,4-dihydro-2H-1-benzopyran-2-yl)methyl) amino)-propyl)tetrahydro-2(1H)-pyrimidinone for treatment of irritable bowel syndrome and other gastrointestinal disorders
05/01/2003US20030083352 Cyclization of a 2-cyano-2-ester-ethylenamine with a primary amine to a 4-ester imidazole
05/01/2003US20030083351 Antihypoxic agents
05/01/2003US20030083349 Antimalaria agents
05/01/2003US20030083333 1,4-Disubstituted benzo-fused compounds
05/01/2003US20030083332 N-heterocyclic derivatives as NOS inhibitors
05/01/2003US20030083327 Inhibitors of Aurora-2 protein kinases and Glycogen synthase kinase-3 (GSK-3); cancer, diabetes, Alzheimer's disease, and schizophrenia treatment
05/01/2003US20030083268 Isoquinoline compounds having antiinfective activity
05/01/2003US20030082769 Human papillomavirus E2 transactivation domain/inhibitor co-crystal and x-ray coordinates defining the inhibitor binding pocket
05/01/2003US20030080323 Novel methine compound, material for organic luminescence element, and organic luminescence element using the same
05/01/2003CA2464256A1 Novel dipeptidyl peptidase iv (dp-iv) inhibitors as anti-diabetic agents
1 ... 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 ... 628